• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AKASA Unveils Gen AI Assistant, Cuts Prior Authorization Time by 50%

by Fred Pennic 03/14/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
AKASA Unveils Gen AI Assistant, Cuts Prior Authorization Time by 50%

What You Should Know:

– AKASA, a leader in generative AI (GenAI) solutions for the revenue cycle, today announced the launch of Authorization Advisor™.

– Authorization Advisor tackles the time-consuming and error-prone process of prior authorization, a major pain point for healthcare providers.

Prior Authorization Made Easy with AI

Prior authorization, a process requiring approval from insurers before delivering certain services, is a significant burden for healthcare providers. It consumes a vast amount of time for revenue cycle teams and often delays patient care. Authorization Advisor tackles this challenge head-on, offering the potential to reduce authorization processing time by up to 50%. This innovative GenAI tool empowers prior authorization specialists with several key features:

  • Interactive Sidebar View: Provides real-time access to patient details and curated clinical documentation directly within the payer portal workflow.
  • Secure and Accurate Data Entry: Ensures patient information is filled out correctly on the payer portal.
  • AI-Powered Document Recommendation: Recommends relevant clinical documents to support authorization requests, eliminating manual searches and improving accuracy.
  • Reduced Manual Workload: Eliminates the need to sift through mountains of documents, freeing up valuable time for specialists.

Health System-Specific AI Model for Accuracy

AKASA’s unique approach utilizes a health system-specific AI model trained on an organization’s own clinical and financial data.  This ensures the AI assistant understands the specific nuances of each healthcare system, unlike generic AI models.  In fact, AKASA’s models have been shown to be 38% more accurate than generic versions when selecting relevant prior authorization documents.

By eliminating manual document searches and suggesting relevant supporting documentation, Authorization Advisor significantly reduces the administrative burden on  patient access teams.  This not only saves time but also helps ensure accurate authorization submissions, leading to faster approvals and improved cash flow for healthcare providers.

“Healthcare leaders are constantly trying to move any dial we can to have a positive impact on our people, processes, and patients,” said John Fox, former president and CEO of Emory and Beaumont Health, and advisor at AKASA. “AKASA is innovating in healthcare with these new generative AI tools. They’re at the right place at the right time to truly transform the revenue cycle by reducing friction and providing real results.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Generative AI, Prior Authorization, Revenue Cycle Management

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |